Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is an open-label, randomized, multicenter study of FPI-2265 (225Ac-PSMA-I\&T). Patient population is adult participants with PSMA positive mCRPC who have had previous treatment with with 177Lu-PSMA-617 or another 177Lu-PSMA radioconjugate (RC). The purpose of the study is to determine the safety and tolerability, and recommended dose and regiment of FPI-2265.
Sponsor: Fusion Pharmaceuticals Inc.
Check if you qualify for this prostate cancer clinical trial in Iowa City, IA
If you're searching for prostate cancer treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.